NCT04551105 - Evaluation of TaiHao Breast Ultrasound Diagnosis Software | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

August 15, 2020

Primary Completion Date

November 1, 2020

Study Completion Date

November 1, 2020

Conditions

Breast CancerBreast Diseases

Interventions

DIAGNOSTIC_TEST

Reader Group X - Session 1

"Each rater in Reader Group X will interpret the dataset A cases in different random order without BR-USCAD DS and interpret the dataset B cases in different random order with BR-USCAD DS."

DIAGNOSTIC_TEST

Reader Group Y - Session 1

"Each rater in Reader Group Y will interpret the dataset A cases in different random order with BR-USCAD DS and interpret the dataset B cases in different random order without BR-USCAD DS."

DIAGNOSTIC_TEST

Reader Group X - Session 2

"Each rater in Reader Group X will interpret the dataset A cases in different random order with BR-USCAD DS and interpret the dataset B cases in different random order without BR-USCAD DS."

DIAGNOSTIC_TEST

Reader Group Y - Session 2

"Each rater in Reader Group Y will interpret the dataset A cases in different random order without BR-USCAD DS and interpret the dataset B cases in different random order with BR-USCAD DS."

Trial Locations (1)

22203

Arlington Innovation Center: Health Research - Virginia Tech, Arlington

All Listed Sponsors

collaborator

Columbia University

OTHER

collaborator

Taipei Veterans General Hospital, Taiwan

OTHER_GOV

collaborator

Virginia Polytechnic Institute and State University

OTHER

lead

TaiHao Medical Inc.

INDUSTRY